Requirement of Transcription Factor NFAT in Developing Atrial Myocardium
Overview
Authors
Affiliations
Nuclear factor of activated T cell (NFAT) is a ubiquitous regulator involved in multiple biological processes. Here, we demonstrate that NFAT is temporally required in the developing atrial myocardium between embryonic day 14 and P0 (birth). Inhibition of NFAT activity by conditional expression of dominant-negative NFAT causes thinning of the atrial myocardium. The thin myocardium exhibits severe sarcomere disorganization and reduced expression of cardiac troponin-I (cTnI) and cardiac troponin-T (cTnT). Promoter analysis indicates that NFAT binds to and regulates transcription of the cTnI and the cTnT genes. Thus, regulation of cytoskeletal protein gene expression by NFAT may be important for the structural architecture of the developing atrial myocardium.
Maghsoudi S, Shuaib R, Van Bastelaere B, Dakshinamurti S Front Pharmacol. 2024; 15:1370506.
PMID: 38633617 PMC: 11021717. DOI: 10.3389/fphar.2024.1370506.
Georges H, Van Campen H, Bielefeldt-Ohmann H, Hansen T Viruses. 2022; 14(3).
PMID: 35336913 PMC: 8949278. DOI: 10.3390/v14030506.
Transcription Factors Involved in the Development and Prognosis of Cardiac Remodeling.
Hong J, Zhang H Front Pharmacol. 2022; 13:828549.
PMID: 35185581 PMC: 8849252. DOI: 10.3389/fphar.2022.828549.
Ni L, Lahiri S, Nie J, Pan X, Abu-Taha I, Reynolds J Cardiovasc Res. 2021; 118(13):2805-2818.
PMID: 34648001 PMC: 9586567. DOI: 10.1093/cvr/cvab325.
Hematopoietic Stem Cell Transcription Factors in Cardiovascular Pathology.
Duddu S, Chakrabarti R, Ghosh A, Shukla P Front Genet. 2020; 11:588602.
PMID: 33193725 PMC: 7596349. DOI: 10.3389/fgene.2020.588602.